However, our clinical data showed that P-gp alone had no effect on DFS or DSS in breast cancer patients who received anthracycline-based chemotherapy, whereas Cbl-b significantly prolonged the survival of P-gp positive patients. This evidence concerns the gene PGP and breast cancer.